These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 21368378)

  • 1. Brain and serum levels of nerve growth factor in a rat model of Alzheimer's disease.
    Gelfo F; Tirassa P; De Bartolo P; Caltagirone C; Petrosini L; Angelucci F
    J Alzheimers Dis; 2011; 25(2):213-7. PubMed ID: 21368378
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preservation of brain nerve growth factor in mild cognitive impairment and Alzheimer disease.
    Mufson EJ; Ikonomovic MD; Styren SD; Counts SE; Wuu J; Leurgans S; Bennett DA; Cochran EJ; DeKosky ST
    Arch Neurol; 2003 Aug; 60(8):1143-8. PubMed ID: 12925373
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monocytes deliver bioactive nerve growth factor through a brain capillary endothelial cell-monolayer in vitro and counteract degeneration of cholinergic neurons.
    Böttger D; Ullrich C; Humpel C
    Brain Res; 2010 Feb; 1312():108-19. PubMed ID: 20004179
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BDNF concentrations are decreased in serum and parietal cortex in immunotoxin 192 IgG-Saporin rat model of cholinergic degeneration.
    Angelucci F; Gelfo F; De Bartolo P; Caltagirone C; Petrosini L
    Neurochem Int; 2011 Aug; 59(1):1-4. PubMed ID: 21672569
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The precursor pro-nerve growth factor is the predominant form of nerve growth factor in brain and is increased in Alzheimer's disease.
    Fahnestock M; Michalski B; Xu B; Coughlin MD
    Mol Cell Neurosci; 2001 Aug; 18(2):210-20. PubMed ID: 11520181
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Repeated nicotine exposure in rats: effects on memory function, cholinergic markers and nerve growth factor.
    Hernandez CM; Terry AV
    Neuroscience; 2005; 130(4):997-1012. PubMed ID: 15652996
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recombinant human NGF-loaded microspheres promote survival of basal forebrain cholinergic neurons and improve memory impairments of spatial learning in the rat model of Alzheimer's disease with fimbria-fornix lesion.
    Gu H; Long D; Song C; Li X
    Neurosci Lett; 2009 Apr; 453(3):204-9. PubMed ID: 19429036
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amyloid beta-induced nerve growth factor dysmetabolism in Alzheimer disease.
    Bruno MA; Leon WC; Fragoso G; Mushynski WE; Almazan G; Cuello AC
    J Neuropathol Exp Neurol; 2009 Aug; 68(8):857-69. PubMed ID: 19606067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Delivery of NGF to the brain: intranasal versus ocular administration in anti-NGF transgenic mice.
    Capsoni S; Covaceuszach S; Ugolini G; Spirito F; Vignone D; Stefanini B; Amato G; Cattaneo A
    J Alzheimers Dis; 2009; 16(2):371-88. PubMed ID: 19221427
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transplantation of NGF secreting primary monocytes counteracts NMDA-induced cell death of rat cholinergic neurons in vivo.
    Zassler B; Humpel C
    Exp Neurol; 2006 Apr; 198(2):391-400. PubMed ID: 16443222
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of galantamine and donepezil for effects on nerve growth factor, cholinergic markers, and memory performance in aged rats.
    Hernandez CM; Gearhart DA; Parikh V; Hohnadel EJ; Davis LW; Middlemore ML; Warsi SP; Waller JL; Terry AV
    J Pharmacol Exp Ther; 2006 Feb; 316(2):679-94. PubMed ID: 16214877
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Brain cholinergic markers and Tau phosphorylation are altered in experimental type 1 diabetes: normalization by electroacupuncture.
    Rocco ML; Pristerà A; Pistillo L; Aloe L; Canu N; Manni L
    J Alzheimers Dis; 2013; 33(3):767-73. PubMed ID: 23001708
    [TBL] [Abstract][Full Text] [Related]  

  • 13. No nerve growth factor response to treatment with memantine in adult rats.
    Lang UE; Mühlbacher M; Hesselink MB; Zajaczkowski W; Danysz W; Danker-Hopfe H; Hellweg R
    J Neural Transm (Vienna); 2004 Feb; 111(2):181-90. PubMed ID: 14767721
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nerve growth factor pharmacology: application to the treatment of cholinergic neurodegeneration in Alzheimer's disease.
    Lapchak PA
    Exp Neurol; 1993 Nov; 124(1):16-20. PubMed ID: 8282073
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential regulation of nerve growth factor and brain-derived neurotrophic factor in a mouse model of learned helplessness.
    Schulte-Herbrüggen O; Chourbaji S; Müller H; Danker-Hopfe H; Brandwein C; Gass P; Hellweg R
    Exp Neurol; 2006 Dec; 202(2):404-9. PubMed ID: 16914143
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Endogenous nerve growth factor in patients with Alzheimer s disease].
    Serrano-Sánchez T; Robinson-Agramonte MA; Lorigados-Pedre L; Díaz-Armesto I; González-Fraguela ME; Dorta-Contreras AJ
    Rev Neurol; 2001 May 1-15; 32(9):825-8. PubMed ID: 11424032
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Protective effects of Panax notoginseng saponins against pathological lesion of cholinergic neuron in rat model with Alzheimer' s disease].
    Zhong Z; Qu Z; Wang N; Wang J; Xie Z; Zhang F; Zhang W; Lu Z
    Zhong Yao Cai; 2005 Feb; 28(2):119-22. PubMed ID: 15981887
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cholinergic neuropathology in a mouse model of Alzheimer's disease.
    German DC; Yazdani U; Speciale SG; Pasbakhsh P; Games D; Liang CL
    J Comp Neurol; 2003 Aug; 462(4):371-81. PubMed ID: 12811807
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Changes in nerve growth factor levels related to age and neurotrophic treatment in non-human primate].
    Lorigados L; Pavón N; Serrano T; Robinson MA; Fernández CI; Alvarez P
    Rev Neurol; 2001 Sep 1-15; 33(5):417-21. PubMed ID: 11727206
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo upregulation of endogenous NGF in the rat brain by the alpha2-adrenoreceptor antagonist dexefaroxan: potential role in the protection of the basalocortical cholinergic system during neurodegeneration.
    Debeir T; Marien M; Ferrario J; Rizk P; Prigent A; Colpaert F; Raisman-Vozari R
    Exp Neurol; 2004 Dec; 190(2):384-95. PubMed ID: 15530877
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.